Central nervous system involvement in acute nonlymphocytic leukemia. A prospective study of adults in remission

The American Journal of Medicine

Volumn 83, Issue 3, 1987, Pages 464-470

  Peterson, Bruce A ^a   Brunning, Richard D ^a   Bloomfield, Clara D ^a   Hurd, David D ^a   Gau, Jane A ^a   Peng, Grace T ^a   Goldman, Anne I ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; DOXORUBICIN; PREDNISONE;

ACUTE NONLYMPHOCYTIC LEUKEMIA; ADULT; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DIAGNOSIS; DRUG THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PROPHYLAXIS;

ACUTE DISEASE; ADULT; FEMALE; HUMAN; LACTATE DEHYDROGENASE; LEUKEMIA; LEUKOCYTE COUNT; MALE; MENINGEAL NEOPLASMS; MURAMIDASE; PROSPECTIVE STUDIES; RISK FACTORS; SPLENOMEGALY; SUPPORT, NON-U.S. GOV'T;

EID: 0023634486     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(87)90756-X     Document Type: Article

References (34)

1. The increasing incidence of central nervous system leukemia in children
2. Neurological complications of acute leukemia in adults: changing rate
3. The incidence of central nervous system leukemia in adults with acute leukemia
4. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside
5. Chemoimmunotherapy with corynebacterium parvum in acute myelocytic leukemia
6. Intensive chemotherapy for acute myelogenous leukemia
7. Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia
8. Contamination of cerebrospinal fluid by vertebral bone-marrow cells during lumbar puncture
9. Central nervous system involvement at presentation in acute granulocytic leukemia
10. Cytosine arabinoside with daunorubicin or Adriamycin for therapy of acute myelocytic leukemia
11. Central nervous system (CNS) surveillance during complete remission (CR) in acute nonlymphocytic leukemia (ANLL)
12. Proposals for the classification of the acute leukaemias
13. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia
14. Intensive five-drug combination chemotherapy for adult acute non-lymphocytic leukemia
15. Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia
16. Long-term disease-free survival in acute nonlymphocytic leukemia
17. Central nervous system (CNS) involvement in the acute myeloid leukemias (AML): the eastern Cooperative oncology group (ECOG) experience
18. Factors that influence the appearance of central nervous system leukemia
19. Infiltration of central nervous system in adult acute myeloid leukaemia
20. Acute granulocytic leukemia
21. Maintenance therapy of adult acute nonlymphocytic leukemia
22. Results of aggressive chemotherapy for acute nonlymphoblastic leukemia in adults
23. Treatment of acute leukemia in adults
24. Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update
25. Acute monoblastic leukemia: a clinical and biologic study of 74 cases
26. Natural history of central nervous system acute leukemia in adults
27. Asymptomatic central nervous system (CNS) leukemia in adults with acute non-lymphocytic leukema (ANLL) in extended remission
28. Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia
29. Association of monocytic leukemia in patients with extreme leukocytosis
30. The acute monocytic leukemias: multidisciplinary studies in 45 patients
31. A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22)
32. Partial deletion of the long arm of chromosome 16 and bone marrow eosinophilia in acute nonlymphocytic leukemia: a new association
33. Intensive postremission therapy in adults with acute nonlymphocytic leukemia with Ara-C by continuous infusion or bolus administration: preliminary results of a CALGB phase I study